SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 22, 2024, reporting events occurring on October 18 and October 21, 2024. The company is incorporated in Delaware and trades on The NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding listing requirements.
Material Changes and Events
- Nasdaq Compliance Grace Period: On October 18, 2024, the Nasdaq Listing and Hearing Review Council granted the company a grace period until March 7, 2025, to regain compliance with Nasdaq Listing Rule 5550(b)(2) (Minimum Value of Listed Securities).
- Compliance Requirement: The rule requires a market value of listed securities of at least $35 million.
- Trading Status: On October 21, 2024, the company was notified that its common stock would resume trading on The Nasdaq Stock Market effective at the opening of trading on Wednesday, October 23, 2024.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial performance, or specific risk factors beyond the immediate listing compliance issue. The primary contingency is the company's ability to meet the $35 million market value requirement by the March 7, 2025 deadline to maintain its listing.
Investor Verification Checklist
- Verify the current market capitalization of BioSig Technologies, Inc. to assess the gap to the $35 million threshold.
- Confirm the stock's trading status on The Nasdaq Capital Market as of October 23, 2024.
- Monitor future filings for updates on the company's plan to achieve compliance by March 7, 2025.
- Note the discrepancy between the requested company name (Streamex Corp.) and the actual registrant (BioSig Technologies, Inc.).